Hussman Strategic Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Hussman Strategic Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.69M	Buy
2024 Q3	–	Sell
2024 Q2	$683K	Hold
2024 Q1	$777K	Hold
2023 Q4	$1.32M	Hold
2023 Q3	$875K	Sell
2023 Q2	$1.48M	Sell
2023 Q1	$1.75M	Buy